Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData Read more
Puma Biotechnology announces presentation of findings from a phase II study of alisertib in endocrine-resistant metastatic breast cancer Read more
PROSEEK study shows no treatment benefit of Vodobatinib in patients with early Parkinson’s Disease Read more
Suven announces randomisation of first patient in Phase-2 POC clinical trial of Ropanicant (SUVN-911) Read more
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib in early Parkinson’s disease Read more
Termination of Ultragenyx’s UX053 Phase I/II study is a minor setback for mRNA therapeutics: GlobalData Read more
Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer Read more